ANG Lifesciences India Ltd
ANG Lifesciences Appoints Mrs. Preeti Sarin as Additional Independent Director
MANAGEMENT
● No Immediate Change
LOW RISK
📅 Filed on BSE: 14 Nov 2026, 09:34 PM IST · BSE ID: 6a57597a-d762-47e1-ad7f-3385989c6e36
View Original BSE Filing (PDF)
💡
In Simple Terms
A new independent director, Mrs. Preeti Sarin, was appointed by the company's board for a five-year term.
🤖 AI Summary
- Mrs. Preeti Sarin appointed Additional Independent Director at ANG Lifesciences India Ltd.
- Director appointment is for five years, effective November 14, 2026, requiring shareholder approval.
- Board considered unaudited standalone and consolidated financial results for Q2 FY27.
- Limited review report by Statutory Auditor M/s Khurana Sharma & Co. was also noted.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Director Appointment Effective Date
14th November, 2026
Director Tenure
five (5) consecutive years
Director Appointment End Date
13th November, 2031
Quarter Ended
30th September 2026
🏢 How This Affects the Company
The appointment of an independent director is intended to strengthen corporate governance and oversight.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders; the appointment is subject to their future approval.
👤
Who Is Affected
All shareholders will be affected by the enhanced board oversight and governance structure.
🔍
Management Signal
The appointment signals management's commitment to adhering to corporate governance norms and strengthening board independence.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List - track these upcoming events
Shareholder meeting to approve Mrs. Preeti Sarin's appointment.
Publication of audited financial results for Q2 FY27.
Any further updates on board committee memberships.
LOW RISK
The filing pertains to a standard management change and routine financial result review.
💡 Investor Takeaway
ANG Lifesciences India Ltd appointed Mrs. Preeti Sarin as Additional Independent Director for a five-year term starting November 14, 2026. Unaudited Q2 FY27 results were also reviewed.
⚖️ Strengths & Concerns
✅ Positives
- Appointment of Mrs. Preeti Sarin as an independent director for a five-year term.
- Company confirms Mrs. Preeti Sarin meets independence criteria under Companies Act, 2013 and SEBI Regulations.
❓ Frequently Asked Questions
Who has been appointed as an Additional Independent Director at ANG Lifesciences India Ltd?
Mrs. Preeti Sarin has been appointed as an Additional Independent Director.
What is the tenure of Mrs. Preeti Sarin's appointment as Independent Director?
Mrs. Preeti Sarin will hold office for a period of five (5) consecutive years from 14th November, 2026 to 13th November, 2031.
What financial results were considered by the Board of ANG Lifesciences India Ltd?
The Board considered the unaudited financial results for the quarter and half-year ended 30th September 2026.
Who is the Statutory Auditor for ANG Lifesciences India Ltd?
M/s Khurana Sharma & Co. is the Statutory Auditor of the Company.
Questions based on this BSE filing only. For information purposes.